![James Francis Winschel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James Francis Winschel
Direttore Finanziario/CFO presso Hamlin Scientific Corp.
Posizioni attive di James Francis Winschel
Società | Posizione | Inizio | Fine |
---|---|---|---|
hVIVO Services Ltd.
![]() hVIVO Services Ltd. Internet Software/ServicesTechnology Services Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford. | Direttore/Membro del Consiglio | 01/10/2014 | - |
Vivtex Corp. | Direttore/Membro del Consiglio | 01/01/2018 | - |
Amministratore Delegato | - | 21/02/2023 | |
Direttore Finanziario/CFO | 01/01/2018 | - | |
Hamlin Scientific Corp. | Direttore Finanziario/CFO | - | - |
Cambridge Science Corp.
![]() Cambridge Science Corp. BiotechnologyHealth Technology Cambridge Science Corp. engages in investing in the medicine. It also engages in improving patient lives through the acceleration of translational research and develops internal drug development programs. The firm finances and manages biotech companies commercializing novel technologies developed in the labs and the research institutions. The company was founded in 2017 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di James Francis Winschel
Precedenti posizioni note di James Francis Winschel
Società | Posizione | Inizio | Fine |
---|---|---|---|
HVIVO PLC | Direttore/Membro del Consiglio | 07/10/2014 | 17/01/2020 |
Independent Dir/Board Member | 01/10/2014 | 17/01/2020 | |
PAREXEL INTERNATIONAL CORPORATION | Direttore Finanziario/CFO | 01/06/2000 | 01/09/2013 |
Corporate Officer/Principal | 04/09/2012 | - | |
U.B. Vehicle Leasing, Inc. | Presidente | 01/01/1999 | 01/05/2000 |
BTM Capital Corp. | Direttore Finanziario/CFO | 01/12/1995 | 01/09/1999 |
The Bank of Tokyo-Mitsubishi, Ltd.
![]() The Bank of Tokyo-Mitsubishi, Ltd. Regional BanksFinance Part of Mitsubishi UFJ Financial Group, Inc., The Bank of Tokyo-Mitsubishi Ltd. provides banking and financial services. The company is based in Tokyo, Japan. | Direttore Finanziario/CFO | 01/01/1995 | 01/01/1998 |
░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░░░ ░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formazione di James Francis Winschel
Syracuse University | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 11 |
Regno Unito | 3 |
Svizzera | 2 |
Posizioni
Director of Finance/CFO | 8 |
Director/Board Member | 5 |
Corporate Officer/Principal | 1 |
Settori
Finance | 4 |
Commercial Services | 3 |
Health Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 13 |
---|---|
PAREXEL International Corp.
![]() PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
U.B. Vehicle Leasing, Inc. | |
BTM Capital Corp. | Finance |
Whirlpool Financial Corp.
![]() Whirlpool Financial Corp. Investment ManagersFinance Part of Whirlpool Corp., Whirlpool Financial Corp. provides financial advisory services. | Finance |
Caremark International, Inc. | Health Services |
Cambrex Corp.
![]() Cambrex Corp. Pharmaceuticals: GenericHealth Technology Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ. | Health Technology |
hVIVO Ltd.
![]() hVIVO Ltd. Miscellaneous Commercial ServicesCommercial Services hVIVO Ltd. engages in the provision of clinical development services with a focus on human disease models. It specializes in human challenge studies using influenza, human rhinovirus, and respiratory syncytial virus for pharmaceutical and biotech companies. The company was founded by John Sidney Oxford in 1989 and is headquartered in London, the United Kingdom. | Commercial Services |
Novimmune SA
![]() Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
The Bank of Tokyo-Mitsubishi, Ltd.
![]() The Bank of Tokyo-Mitsubishi, Ltd. Regional BanksFinance Part of Mitsubishi UFJ Financial Group, Inc., The Bank of Tokyo-Mitsubishi Ltd. provides banking and financial services. The company is based in Tokyo, Japan. | Finance |
hVIVO Services Ltd.
![]() hVIVO Services Ltd. Internet Software/ServicesTechnology Services Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford. | Technology Services |
Vivtex Corp. | |
Hamlin Scientific Corp. | |
Cambridge Science Corp.
![]() Cambridge Science Corp. BiotechnologyHealth Technology Cambridge Science Corp. engages in investing in the medicine. It also engages in improving patient lives through the acceleration of translational research and develops internal drug development programs. The firm finances and manages biotech companies commercializing novel technologies developed in the labs and the research institutions. The company was founded in 2017 and is headquartered in Cambridge, MA. | Health Technology |